Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

June 2017 - FRMC

News

News
06/12/2017
As pharmacy benefit managers negotiate deep discounts for reference biologics, biosimilar prices are not making the spending impact that payers had hoped for. 
As pharmacy benefit managers negotiate deep discounts for reference biologics, biosimilar prices are not making the spending impact that payers had hoped for. 
As pharmacy benefit managers...
06/12/2017
First Report Managed Care
06/09/2017
After an initial failed launch, the American Health Care Act will move to the Senate for consideration and further development. We spoke with managed care experts about the difficulties of passing a bill that improves health care coverage...
After an initial failed launch, the American Health Care Act will move to the Senate for consideration and further development. We spoke with managed care experts about the difficulties of passing a bill that improves health care coverage...
After an initial failed launch,...
06/09/2017
First Report Managed Care
Pharmacy Insight
06/08/2017
Yearly incremental drug price increases are becoming an unsustainable burden on specialty pharmacy spending.
Yearly incremental drug price increases are becoming an unsustainable burden on specialty pharmacy spending.
Yearly incremental drug price...
06/08/2017
First Report Managed Care
Department
06/08/2017
A recent report found that global spending on oncology therapeutics and supportive care drugs have increased by billions of dollars. 
A recent report found that global spending on oncology therapeutics and supportive care drugs have increased by billions of dollars. 
A recent report found that...
06/08/2017
First Report Managed Care

Department

News Connection
06/08/2017
The California Senate recently passed its plan to establish a single-payer health system in the State; however, a huge cost burden and logistical barriers will need solutions before the plan can become a reality. 
The California Senate recently passed its plan to establish a single-payer health system in the State; however, a huge cost burden and logistical barriers will need solutions before the plan can become a reality. 
The California Senate recently...
06/08/2017
First Report Managed Care
Formulary Frontlines®
06/08/2017
Patients diagnosed with neuroendocrine tumors often experience different burdens associated with the disease resulting in costly treatments of thousands of dollars per year.
Patients diagnosed with neuroendocrine tumors often experience different burdens associated with the disease resulting in costly treatments of thousands of dollars per year.
Patients diagnosed with...
06/08/2017
First Report Managed Care
News Connection
06/08/2017
Multiple phase 3 HIV trials suggest fixed-dose combination treatment regimens containing Gilead's investigational agent bictegravir are noninferior to those containing GlaxoSmithKline’s Tivicay.
Multiple phase 3 HIV trials suggest fixed-dose combination treatment regimens containing Gilead's investigational agent bictegravir are noninferior to those containing GlaxoSmithKline’s Tivicay.
Multiple phase 3 HIV trials...
06/08/2017
First Report Managed Care

Advertisement

Advertisement

Advertisement